All News

CMS has proposed the mandatory Radiation Oncology Model, which would cover radiation therapy spanning a 90-day episode.

Research led by authors from the University of Pennsylvania find widening geographic and rural-urban disparities in the story of rising white mortality rates.

HHS has launched a summit to streamline and improve quality programs across the agency; more than 160 children with type 1 diabetes (T1D) appeared before a Senate committee to ask for more funding for the Special Diabetes Program; the CDC has confirmed 11 cases of a rare polio-like illness in 8 states.

HHS Secretary Alex Azar's proposed rule to eliminate drug rebates and pass discounts directly to the patient is getting dropped by the White House.

Following an executive order from President Donald Trump, HHS announced the launch of Advancing American Kidney Health, an initiative to improve the health of the 37 million Americans living with kidney disease, by releasing 5 new payment models.

During oral arguments at the 5th Circuit Court of Appeals, Republican-appointed judges voiced their skepticism over the constitutionality of the individual mandate without the imposed tax while Judge Carolyn Dineen King—appointed by President Jimmy Carter in 1979—did not ask any questions or make any comments about the case.

In addition to motor symptoms, Parkinson disease (PD) can also result in nonmotor symptoms like cognitive impairment and eventual dementia. Researchers have identified brain structure changes associated with worsening cognition in hopes that it can lead to a better understanding of the mechanisms of PD.

Amid fears of large coverage losses, New Hampshire is delaying its Medicaid work requirements; California has become the first state to offer Medicaid to young undocumented immigrants; physicians have delivered a healthy baby from the transplanted uterus of a deceased donor for the first time in the United States.

Pediatric patients with relapsed or refractory B acute lymphoblastic leukemia (B-ALL) with minimal residual disease (MRD) who were treated with blinatumomab proceeded to hematopoietic cell transplant (HCT) without delay and had limited side effects.

In 2018, 33% of accountable care organizations (ACOs) assumed downside risk, up from 28% in 2012.

US District Court Judge Amit P. Mehta has ruled that HHS does not have the authority to require drug manufacturers to list the prices of their drugs in television ads.

The Trump administration is expected to unveil a series of initiatives on Wednesday, including new payment models to overhaul kidney disease care; a report from the inspector general of HHS found widespread hospice deficiencies; the number of undocumented immigrant children in California’s Medicaid program is slowly declining even as the state prepares to expand coverage to undocumented young adults.

Poor interpretation of imaging is the top reason for oncology malpractice lawsuits.

As President Trump spoke about the environment and the economy, the American Lung Association and the American Public Health Association said that they will sue the administration over its decision to repeal the Clean Power Plan, which was passed under the Obama administration to reduce carbon pollution from power plants.

Combining CRISPR with long-acting slow-effective release antiretroviral therapy—a recently developed therapeutic strategy—the researchers were able to effectively eliminate replication-competent HIV DNA from the genomes of approximately 30% of infected humanized mice.

Time to diagnosis, the interval that passes from first symptom presentation until diagnosis, varies by cancer type among children, adolescents, and young adults and may be affected by clinical and sociodemogrpahic factors.

The 5th Circuit Court of Appeals in New Orleans will hear arguments Tuesday in a lawsuit backed by the Trump administration seeking to reverse the Affordable Care Act (ACA); legislators return from a holiday break to try and reach an agreement on healthcare cost issues; a growing number of Americans in rural areas are turning to telehealth appointments amid hospital closings and a shortage of local primary care doctors, specialists, and other providers.

A new study by Willis Towers Watson finds technology plays an increasingly important role in employee health benefits.

Comorbidities are common for patients with asthma and chronic obstructive pulmonary disease (COPD) overlap.

Changes to Medigap as part of the Medicare Access and CHIP Reauthorization Act go into action beginning next year.

A new study by Mayo Clinic Researchers calls into question the current standard of care for treating smoldering multiple myeloma.

A study comparing the efficacy of burosumab with conventional treatment—oral phosphate and active vitamin D—found that burosumab, which blocks FGF23, was significantly more effective in alleviating symptoms.

As social determinants of health are being more intensely researched, one determinant that is already well understood and has a number of interventions in place and being studied is housing. Here are 5 things about housing in healthcare.

Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.

Some generic drugs may actually cost Medicare Part D beneficiaries more out-of-pocket than brand-name drugs because brand-name manufacturers can offer discounts that generic drug makers cannot pay.

The Triple Aim will be within reach when there is greater stakeholder engagement and systemic ownership. A good start is for more employers to provide more American workers with access to high-quality wellness programs that can impact chronic disease with population health strategies.

This week, we recap the top managed care news from the first half of 2019, including outcomes from some of the biggest diabetes trials, research into the annual Medicare wellness visit, and an experimental treatment in Parkinson disease.

A recent study examined the association between patients with secondary myelofibrosis (SMF) and later development of nonhematological second primary malignancies (SPM).